[{"Assets_0_Q2_USD":136133000.0,"CommonStockSharesOutstanding_0_Q2_shares":60849236.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-51361000.0,"NetIncomeLoss_1_Q2_USD":-29908000.0,"NetIncomeLoss_2_Q2_USD":-53225000.0,"StockholdersEquity_0_Q2_USD":118719000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20171113"}]